Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients
- PMID: 20085121
Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients
Abstract
Background and objective: Insulin resistance and adipocytokines have been associated with fat liver and non-alcoholic fat liver disease (NAFLD). The aim of this research was to study the influence of insulin resistance and adipocytokines in presurgical morbid obese patients on elevated serum alanine aminotransferase (ALT) as an indicator of NAFLD.
Subjects and methods: A population of 65 presurgical morbid obese patients was analyzed in a cross sectional study. HOMA-IR was calculated as indicator of insulin resistance. Adipocytokines (leptin, resistin, adiponectin, Interleukin-6 and TNF alpha) blood levels were measured.
Results: Patients were classified as group I (n=33) when serum ALT activity was normal or group II (NAFLD patients; n=32) when serum ALT activity was greater than the median value of the group (> or =24 UI/L). In NAFLD group, BMI, weight, fat mass, waist to hip ratio, waist circumference, HOMA and insulin levels were higher than control group. Adiponectin levels were lower in group II than I. Anthropometric parameters were higher in both groups. In the multivariate analysis with dietary intake-, age- and sex-adjusted ALT concentration as a dependent variable, only HOMA remained as an independent predictor in the model (F=12.1; p<0.05). ALT concentration increased 0.48 UI/L (CI95%: 0.19-0.76) for each unit of HOMA increased.
Conclusion: Anthropometric parameters and insulin resistance are associated with elevated serum alanine aminotransferase in obese morbid patients with lower levels of adiponectin. However, in a multiple regression model only insulin resistance remained in the model.
Similar articles
-
Influence of insulin resistance in obese patients on elevated serum alanine aminotransferase.Eur Rev Med Pharmacol Sci. 2007 Jan-Feb;11(1):21-5. Eur Rev Med Pharmacol Sci. 2007. PMID: 17405346
-
Role of insulin resistance and adipocytokines on serum alanine aminotransferase in obese patients with type 2 diabetes mellitus.Eur Rev Med Pharmacol Sci. 2013;17(15):2059-64. Eur Rev Med Pharmacol Sci. 2013. PMID: 23884827
-
Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.Diabetes Res Clin Pract. 2008 Sep;81(3):321-6. doi: 10.1016/j.diabres.2008.05.006. Epub 2008 Jun 20. Diabetes Res Clin Pract. 2008. PMID: 18571268
-
Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines.Curr Mol Med. 2009 Apr;9(3):299-314. doi: 10.2174/156652409787847191. Curr Mol Med. 2009. PMID: 19355912 Review.
-
Obesity and cancer, a case for insulin signaling.Cell Death Dis. 2015 Dec 31;6(12):e2037. doi: 10.1038/cddis.2015.381. Cell Death Dis. 2015. PMID: 26720346 Free PMC article. Review.
Cited by
-
Impact of weight-loss surgery and diabetes status on serum ALT levels.Obes Surg. 2012 Oct;22(10):1540-7. doi: 10.1007/s11695-012-0677-1. Obes Surg. 2012. PMID: 22610995 Free PMC article.
-
Differential gene expression profiling of human bone marrow-derived mesenchymal stem cells during adipogenic development.BMC Genomics. 2011 Sep 24;12:461. doi: 10.1186/1471-2164-12-461. BMC Genomics. 2011. PMID: 21943323 Free PMC article.
-
Changes in alanine aminotransferase in adults with severe and complicated obesity during a milk-based meal replacement programme.Nutr Metab (Lond). 2020 Oct 16;17:87. doi: 10.1186/s12986-020-00512-5. eCollection 2020. Nutr Metab (Lond). 2020. PMID: 33072167 Free PMC article.